Internalization and cytotoxicity of graphene oxide and carboxyl graphene nanoplatelets in the human hepatocellular carcinoma cell line Hep G2

BackgroundGraphene and graphene derivative nanoplatelets represent a new generation of nanomaterials with unique physico-chemical properties and high potential for use in composite materials and biomedical devices. To date little is known about the impact graphene nanomaterials may have on human health in the case of accidental or intentional exposure. The objective of this study was to assess the cytotoxic potential of graphene nanoplatelets with different surface chemistry towards a human hepatoma cell line, Hep G2, and identify the underlying toxicity targets.MethodsGraphene oxide (GO) and carboxyl graphene (CXYG) nanoplatelet suspensions were obtained in water and culture medium. Size frequency distribution of the suspensions was determined by means of dynamic light scattering. Height, lateral dimension and shape of the nanoplatelets were determined using atomic force and electron microscopy. Cytotoxicity of GO and CXYG nanoplatelets was assessed in Hep G2 cells using a battery of assays covering different modes of action including alterations of metabolic activity, plasma membrane integrity and lysosomal function. Induction of oxidative stress was assessed by measuring intracellular reactive oxygen species levels. Interaction with the plasma membrane, internalization and intracellular fate of GO and CXYG nanoplatelets was studied by scanning and transmission electron microscopy.ResultsSupplementing culture medium with serum was essential to obtain stable GO and CXYG suspensions. Both graphene derivatives had high affinity for the plasma membrane and caused structural damage of the latter at concentrations as low as 4 μg/ml. The nanoplatelets penetrated through the membrane into the cytosol, where they were concentrated and enclosed in vesicles. GO and CXYG accumulation in the cytosol was accompanied by an increase in intracellular reactive oxygen species (ROS) levels, alterations in cellular ultrastructure and changes in metabolic activity.ConclusionsGO and CXYG nanoplatelets caused dose- and time-dependent cytotoxicity in Hep G2 cells with plasma membrane damage and induction of oxidative stress being important modes of toxicity. Both graphene derivatives were internalized by Hep G2, a non-phagocytotic cell line. Moreover, they exerted no toxicity when applied at very low concentrations (< 4 μg/ml). GO and CXYG nanoplatelets may therefore represent an attractive material for biomedical applications.

[1]  Deepthy Menon,et al.  Differential nano-bio interactions and toxicity effects of pristine versus functionalized graphene. , 2011, Nanoscale.

[2]  Zhuang Liu,et al.  Graphene based gene transfection. , 2011, Nanoscale.

[3]  Omid Akhavan,et al.  Toxicity of graphene and graphene oxide nanowalls against bacteria. , 2010, ACS nano.

[4]  G. Pastorin,et al.  Graphene for controlled and accelerated osteogenic differentiation of human mesenchymal stem cells. , 2011, ACS nano.

[5]  Alexander Star,et al.  Biodegradation of single-walled carbon nanotubes through enzymatic catalysis. , 2008, Nano letters.

[6]  W. Rosenau,et al.  Target cell lysis: ultrastructural and cytoskeletal alterations. , 1984, Journal of immunology.

[7]  A. Nel,et al.  Ultrafine particulate pollutants induce oxidative stress and mitochondrial damage. , 2002, Environmental health perspectives.

[8]  S. Sollott,et al.  Mitochondrial ROS-induced ROS release: an update and review. , 2006, Biochimica et biophysica acta.

[9]  N. He,et al.  Preparation of graphene quantum dots for bioimaging application. , 2012, Journal of nanoscience and nanotechnology.

[10]  Kai Yang,et al.  In vitro and in vivo behaviors of dextran functionalized graphene , 2011 .

[11]  Omid Akhavan,et al.  Size-dependent genotoxicity of graphene nanoplatelets in human stem cells. , 2012, Biomaterials.

[12]  He Shen,et al.  Biomedical Applications of Graphene , 2012, Theranostics.

[13]  P. Mcneil,et al.  Repairing a torn cell surface: make way, lysosomes to the rescue. , 2002, Journal of Cell Science.

[14]  Agnes B Kane,et al.  Biological interactions of graphene-family nanomaterials: an interdisciplinary review. , 2012, Chemical research in toxicology.

[15]  Zhijun Zhang,et al.  Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs. , 2010, Small.

[16]  Roel P F Schins,et al.  Inhaled particles and lung cancer. Part A: Mechanisms , 2004, International journal of cancer.

[17]  J. Kong,et al.  Graphene substrates promote adherence of human osteoblasts and mesenchymal stromal cells , 2010 .

[18]  Fang Liu,et al.  Strongly green-photoluminescent graphene quantum dots for bioimaging applications. , 2011, Chemical communications.

[19]  Yuan Ping,et al.  Chitosan-functionalized graphene oxide as a nanocarrier for drug and gene delivery. , 2011, Small.

[20]  Imre Dékány,et al.  Evolution of surface functional groups in a series of progressively oxidized graphite oxides , 2006 .

[21]  P. Mcneil,et al.  Plasma membrane disruption: repair, prevention, adaptation. , 2003, Annual review of cell and developmental biology.

[22]  Zhuoxuan Lu,et al.  Enhanced chemotherapy efficacy by sequential delivery of siRNA and anticancer drugs using PEI-grafted graphene oxide. , 2011, Small.

[23]  J. W. McClure Diamagnetism of Graphite , 1956 .

[24]  S. K. Sundaram,et al.  Adsorbed proteins influence the biological activity and molecular targeting of nanomaterials. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[25]  P. Wallace The Band Theory of Graphite , 1947 .

[26]  Andre K. Geim,et al.  Electric Field Effect in Atomically Thin Carbon Films , 2004, Science.

[27]  W. N. Chen,et al.  Cytotoxicity evaluation of oxidized single-walled carbon nanotubes and graphene oxide on human hepatoma HepG2 cells: an iTRAQ-coupled 2D LC-MS/MS proteome analysis. , 2012, Toxicological sciences : an official journal of the Society of Toxicology.

[28]  SUPARNA DUTTASINHA,et al.  Graphene: Status and Prospects , 2009, Science.

[29]  Yongsheng Chen,et al.  High-Efficiency Loading and Controlled Release of Doxorubicin Hydrochloride on Graphene Oxide , 2008 .

[30]  Jim E Riviere,et al.  Pharmacokinetics of nanomaterials: an overview of carbon nanotubes, fullerenes and quantum dots. , 2009, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[31]  Wei Wei,et al.  The role of the lateral dimension of graphene oxide in the regulation of cellular responses. , 2012, Biomaterials.

[32]  Judith Klein-Seetharaman,et al.  Carbon nanotubes degraded by neutrophil myeloperoxidase induce less pulmonary inflammation. , 2010, Nature nanotechnology.

[33]  Liangzhu Feng,et al.  Graphene in biomedicine: opportunities and challenges. , 2011, Nanomedicine.

[34]  Xin Huang,et al.  Multi-functionalized graphene oxide based anticancer drug-carrier with dual-targeting function and pH-sensitivity , 2011 .

[35]  Yang Xu,et al.  Cytotoxicity effects of graphene and single-wall carbon nanotubes in neural phaeochromocytoma-derived PC12 cells. , 2010, ACS nano.

[36]  R J Gonzalez,et al.  Evaluation of hepatic subcellular fractions for Alamar blue and MTT reductase activity. , 2001, Toxicology in vitro : an international journal published in association with BIBRA.

[37]  A. Bianco,et al.  Oxidative biodegradation of single- and multi-walled carbon nanotubes. , 2011, Nanoscale.

[38]  Ken Donaldson,et al.  Graphene-based nanoplatelets: a new risk to the respiratory system as a consequence of their unusual aerodynamic properties. , 2012, ACS nano.

[39]  Rachael M. Crist,et al.  Autophagy and lysosomal dysfunction as emerging mechanisms of nanomaterial toxicity , 2012, Particle and Fibre Toxicology.

[40]  Yanli Chang,et al.  In vitro toxicity evaluation of graphene oxide on A549 cells. , 2011, Toxicology letters.

[41]  Andre K. Geim,et al.  The rise of graphene. , 2007, Nature materials.

[42]  Jacek Klinowski,et al.  Structure of Graphite Oxide Revisited , 1998 .

[43]  Andre K. Geim,et al.  Two-dimensional atomic crystals. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[44]  S. Bose,et al.  Recent advances in graphene-based biosensors. , 2011, Biosensors & bioelectronics.

[45]  Chwee Teck Lim,et al.  Origin of enhanced stem cell growth and differentiation on graphene and graphene oxide. , 2011, ACS nano.

[46]  Baohong Liu,et al.  pH-controlled delivery of doxorubicin to cancer cells, based on small mesoporous carbon nanospheres. , 2012, Small.

[47]  A. Clauss,et al.  Dünnste Kohlenstoff-Folien , 1962 .

[48]  J. Turrens,et al.  Mitochondrial formation of reactive oxygen species , 2003, The Journal of physiology.

[49]  R. Misra,et al.  Structure-process-property relationship of the polar graphene oxide-mediated cellular response and stimulated growth of osteoblasts on hybrid chitosan network structure nanocomposite scaffolds. , 2011, Acta biomaterialia.

[50]  R. P. Swatloski,et al.  Recent progress in graphene-related nanotechnologies. , 2009, Recent patents on nanotechnology.

[51]  R. Car,et al.  Single Sheet Functionalized Graphene by Oxidation and Thermal Expansion of Graphite , 2007 .

[52]  E. Land,et al.  Photocatalytic and free radical interactions of the heterocyclic N-oxide resazurin with NADH, GSH, and Dopa. , 1996, Archives of biochemistry and biophysics.

[53]  G. Semenoff,et al.  Condensed-Matter Simulation of a Three-Dimensional Anomaly , 1984 .

[54]  Mayra S. Artiles,et al.  Graphene-based hybrid materials and devices for biosensing. , 2011, Advanced drug delivery reviews.

[55]  Vivian R. Dayeh,et al.  Rainbow Trout Gill Cell Line Microplate Cytotoxicity Test , 2005 .

[56]  Wei Gao,et al.  New insights into the structure and reduction of graphite oxide. , 2009, Nature chemistry.

[57]  C. McCulloch,et al.  Partners in Protection: Interdependence of Cytoskeleton and Plasma Membrane in Adaptations to Applied Forces , 2000, The Journal of Membrane Biology.

[58]  S. Stankovich,et al.  Graphene-based composite materials , 2006, Nature.

[59]  Xiaoling Yang,et al.  Graphene quantum dots: emergent nanolights for bioimaging, sensors, catalysis and photovoltaic devices. , 2012, Chemical communications.

[60]  陳煥文 世界智慧財產權組織[The World Intellectual Property Organization, WIPO] 仲裁規則評釋 , 1996 .

[61]  Christy L Haynes,et al.  Cytotoxicity of graphene oxide and graphene in human erythrocytes and skin fibroblasts. , 2011, ACS applied materials & interfaces.

[62]  I-Wei Chen,et al.  Quantum‐Dot‐Tagged Reduced Graphene Oxide Nanocomposites for Bright Fluorescence Bioimaging and Photothermal Therapy Monitored In Situ , 2012, Advanced materials.

[63]  Jing Kong,et al.  Antibacterial activity of graphite, graphite oxide, graphene oxide, and reduced graphene oxide: membrane and oxidative stress. , 2011, ACS nano.

[64]  Aron Pinczuk,et al.  The 2010 Nobel Prize in Physics , 2010 .

[65]  Bengt Fadeel,et al.  Mechanisms of carbon nanotube-induced toxicity: focus on oxidative stress. , 2012, Toxicology and applied pharmacology.

[66]  Robert Gelein,et al.  EXTRAPULMONARY TRANSLOCATION OF ULTRAFINE CARBON PARTICLES FOLLOWING WHOLE-BODY INHALATION EXPOSURE OF RATS , 2002, Journal of toxicology and environmental health. Part A.

[67]  Xinyuan Liu,et al.  Biodurability of Single-Walled Carbon Nanotubes Depends on Surface Functionalization. , 2010, Carbon.

[68]  M. Pavelka,et al.  Functional Ultrastructure: Atlas of Tissue Biology and Pathology , 2005 .

[69]  Jie Huang,et al.  Polyethylenimine-functionalized graphene oxide as an efficient gene delivery vector , 2011 .

[70]  Ying Liu,et al.  The triggering of apoptosis in macrophages by pristine graphene through the MAPK and TGF-beta signaling pathways. , 2012, Biomaterials.

[71]  Mark R Wiesner,et al.  Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm. , 2006, Nano letters.

[72]  Jiali Zhang,et al.  Biocompatibility of Graphene Oxide , 2010, Nanoscale research letters.